Compare Medpace Holdings Inc (MEDP) vs Prudential Financial Inc (PRU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Prudential Financial Inc — how do they compare? Medpace Holdings Inc trades at $598 (market cap $16.90B), while Prudential Financial Inc trades at $123 (market cap $42.20B). The key difference: Prudential Financial Inc is far larger — about 2.5× Medpace Holdings Inc's market cap, and Prudential Financial Inc pays a 4.58% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | PRU | |
|---|---|---|
Market Cap | $16.90B | $42.20B |
Sector | Technology | Financials |
52-Week High | $620.59 | $123.93 |
52-Week Low | $393.42 | $92.00 |
Enterprise Value | $16.52B | $70.98B |
Dividend Yield | — | 4.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $596.98, down 0.9% on the day but near its 52-week highs. The stock shows strong technical momentum with bullish moving averages and recent golden cross formation. Fundamentally, the company delivered three consecutive quarterly earnings beats with Q2 2026 EPS of $4.25 beating expectations of $3.98. Revenue growth remains robust at 17.2% year-over-year in Q2 2026, supported by record net bookings and a $3.0 billion backlog.
MEDP presents a growth story with strong fundamentals but trades at premium valuations (P/E 35.58, P/S 6.27). The primary investment opportunity lies in continued execution on record bookings and backlog conversion. Key risks include the ongoing shareholder litigation investigation and potential valuation compression if growth moderates. Analyst consensus targets $599.57 with 21% buy ratings, suggesting limited near-term upside from current levels.
Prudential Financial (PRU) trades at $122.63, up 0.43% on the day, with a bullish technical signal from moving averages and recent earnings beats in Q1 and Q2 2026. The company reported Q2 EPS of $4.08, exceeding expectations, driven by strength in PGIM and international segments. Valuation remains attractive with a P/E of 11.09 and P/S of 0.66, while a $1.40 quarterly dividend supports income appeal.
Outlook is cautiously optimistic given earnings momentum and strategic focus on capital-light operations, but risks include sensitivity to interest rates and regulatory changes in key markets like China. Analyst consensus is mixed with a Hold rating predominating, though institutional holdings show increased interest, suggesting potential for upside if execution continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Prudential Financial Inc
Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →
